Belarus vs Chad: The number of people with susceptibility test result for rifampicin
Belarus
100
in 2021
Chad
100
in 2021
Belarus rank
2nd
Chad rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Belarus
- Chad
How they compare
Belarus currently reports 100 against 100 in Chad, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Belarus ahead.
Belarus ranks 2nd and Chad ranks 2nd of 146 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 12.46 | 87.54 | Belarus |
| 2020s | 100 | 69.28 | 30.72 | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belarus or Chad?
- Belarus, at 100 against 100 in Chad as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belarus and Chad?
- 0, with Belarus ahead.
- How many years of comparable data are there for Belarus and Chad?
- 5 years are reported by both, from 2017 to 2021.
- How do Belarus and Chad rank globally for the number of people with susceptibility test result for rifampicin?
- Belarus ranks 2nd and Chad ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.